Product Name: Human Siglec-2 / CD22 Antibody (Pinatuzumab, Research Use)
Catalog Number: NBR-0870
Target Name: Siglec-2 / CD22
Trade Name: Pinatuzumab
Antibody Drug Description: Pinatuzumab vedotin is an anti-CD22 ADC and polatuzumab vedotin an anti-CD79B ADC that are both linked to the microtubule-disrupting agent monomethyl auristatin E (MMAE). Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name:  CD22
Synonyms: SIGLEC-2; SIGLEC2
Target Description: Mediates B-cell B-cell interactions. May be involved in the localization of B-cells in lymphoid tissues. Binds sialylated glycoproteins; one of which is CD45.
Ensembl: ENSG00000012124
Uniprot:  P20273